LabStyle Innovations Corp. (OTCQB:DRIO) Disclaimer Regarding - - PowerPoint PPT Presentation
LabStyle Innovations Corp. (OTCQB:DRIO) Disclaimer Regarding - - PowerPoint PPT Presentation
Thriving with Diabetes In the mHealth Era LabStyle Innovations Corp. (OTCQB:DRIO) Disclaimer Regarding Forward-Looking Statements This presentation of LabStyle Innovations Corp. (the Company ) and statements of the Company s management
www.mydario.com
Disclaimer Regarding Forward-Looking Statements This presentation of LabStyle Innovations Corp. (the “Company”) and statements of the Company’s management or agents related thereto contain or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act"). Words such as "seek," "intend," "believe," "plan," "estimate," "expect," "anticipate“, ‘will”, “would” and other similar expressions all denote forward-looking statements within the meaning of the Act. Factors that could cause or contribute to such differences include the Company’s compliance with regulatory requirements, the Company’s status as a new public company, the impact of current and any future competition, as well as other factors and risks discussed in the Company's filings (including the results of the company’s commercial and regulatory plans for Dario™) with the U.S. Securities and Exchange Commission. Readers are cautioned that actual results may differ significantly from those set forth in the forward-looking
- statements. The Company undertakes no obligation to publicly update any forward-looking
statements, whether as a result of new information, future events or otherwise, except as required by applicable law. In addition, readers are cautioned that any estimates, forecasts or projections contained in this presentation or as may be discussed by Company management or its agents have been prepared by Company management in good faith on a basis believed to be reasonable. However, such estimates, forecasts and projections involve significant elements of subjective judgment and analysis and no representation can be made as to their attainability. No representation or warranty (express or implied) is made or is to be relied upon as a promise or representation as to the future performance of the Company. Readers are cautioned that such estimates, forecasts or projections have not been audited and have not been prepared in conformance with generally accepted accounting principles.
Executive Summary
www.mydario.com
- Public OTC (OTCQB:DRIO)
- Unique combination of medical device
and Health IT solution.
Company Product Opportunity Market
- Diabetes – Diagnostic $12B + $254B
- Extend to other chronic disease
- Multiple revenue streams (disposable)
- Unique patent portfolio
- Digitalizing the monitoring market
- Post reimbursement in Europe
- Success in initial launch
- Use of proceeds – supply on existing
demand
Flagship: Dario Personalized Smart Meter for Diabetes
Almost 10% of Americans today 1 in 3 American adults by 2050 The 5th leading cause of death in the world
www.mydario.com
Medical Companies Have Spent Millions To Improve This Pack
www.mydario.com
Traditional Glucose Meter
Patients Still Have to Manage Their Own Condition Most of the Time
4 hours 8,756 Hours
www.mydario.com
Visit Doctor Alone Patients need to take decisions by their own day by day and hour by hour
To Manage Diabetes Effectively You Need a Combination of:
Tools Motivation Insight
www.mydario.com
While traditional medical device focus mainly on tools
Dario Provides Diagnostic Device combined with a software to support and personalize the treatment
www.mydario.com
Compact Tiny blood sample Highly accurate All-in-one device Automatically log & monitor Actionable alerts A1C estimates
Simple to use, Smart Meter™ Plugs into smartphone Pocket-sized all-in-one Insight & Disease Management Personal pattern recognition & Decision support You’re not alone Peer & Professional support
Value to Patients
Smart Meter
Insight
Support
www.mydario.com
Value to Payers
= =
Better testing & compliance Savings Better care & prevention
www.mydario.com
Digitalizing the test strip market – cost saving
Value to Supporters
Easier monitoring & remote support
Parents & children
www.mydario.com
Adults & older parents Caregivers & PWDs
Multiple Revenue Streams
- Out of pocket & reimbursement
- Disposable Strips (razorblade model)
- Healthcare professionals - licenses
- Payer risk-management & cost
reduction
- Clinical studies, trial recruitment
- Partnerships
Software Platform
Device & Disposables Data Monetization
www.mydario.com
Disposable – Growing Market
$12b $27b (Up 170%)
2013 2022
www.mydario.com
Value Creation Flow
Q4
www.mydario.com
Q1 Q2
CE Mark
Q3 Q4 Q1
Launch
UK NZ Italy
Extend 6 countries
Canada Australia Holland
Launch USA
2014 2015
Multi Revenue Streams
Penetration by Q2/2015
www.mydario.com
7 countries Diabetes Population Potential penetration 2015 New Zealand, UK, Italy USA, Canada, Australia, Netherlands 38M patients 7.4M insulin dependent 0.2% of the insulin dependent population is 62K users
Competitive Advantage
www.mydario.com
BlueStar WellDoc MySugr Glooko iBGStar Dario Software Platform
Only App Only App Only iOS
Embedded Medical Device
Smart Insight
Real Time
Real Time Data Capture
DarioTM: The Only Medical Device & Real-Time Software Solution
B2C
Digital Marketing App Users
Via Distributors
B2B
Sales Force Healthcare Professionals
Dario Direct
www.mydario.com
www.mydario.com
UK Launch - Case Study
Good Feedback – Strong Demand Dario is branded as personalized and patient
- riented
Digital marketing is very effective Build fast strong community
www.mydario.com
UK – Users Testimonial
Why Dario Why Now
www.mydario.com
- Disposable – Low hanging fruit – Existing market
with existing codes – Reimbursement approved.
- Very big potential around the data and software
- Shortly after launch (weeks)
- 1,300 device users
- 16,000 App Downloads
- Very good market feedback – high demand
- High quality standards (top 30% in the market)
- Accuracy – compliance with new standards
- Rich patent portfolio
- 8 pending, 1 granted, 3 utility model
- Major patent on medical device integration into
smartphone
www.mydario.com
Movie
https://www.youtube.com/watch?v=_XnJzQhcfpI
Erez Raphael CEO & President Gadi Levin CFO David Edelman Director Product Strategy
Seasoned executive with significant experience in publicly listed companies, capital market financings, accounting and financial management. More than 15 years of software business experience, including managing positions in product development at both mobile and semi-conductor companies.
Eran Kurman VP, Global Strategy
Over 16 years of executive leadership in the Medical Device Industry. He has extensive experience in global strategic marketing, business development, and clinical development knowledge.
Experienced Management Team
Shosh Friedman VP Clinical and Regulatory Affairs (FRAP RAC) Dror Bacher VP, R&D
20 years of experience in building product organizations – from Design to commercialization. Formerly with Amdocs (NYSE: DOX) and Nokia-Siemens. Entrepreneur and patient advocate who has dedicated his career to using technology to improve health and
- happiness. President of Diabetes Daily, a leading online
community and educational platform. Former SVP Clinical and Regulatory Affairs at Given Imaging (NASDAQ:GIVN). More than 20 years in clinical, regulatory affairs and QA systems.
www.mydario.com
Over 16 years of executive leadership in the Medical Device Industry. He has extensive experience in global strategic marketing, business development, and clinical development knowledge. Entrepreneur and patient advocate who has dedicated his career to using technology to improve health and
- happiness. President of Diabetes Daily, a leading online
community and educational platform.
Oren Fuerst, PhD
Chairman & Co-Founder
Malcolm Hoenlein Director
- Dr. Steven Kaplan
Director
CEO, Executive Vice-Chairman, Conference of Major American Jewish Organizations. Director, Council of Foreign Relations Seasoned entrepreneur and investor Founder of Tevel Global & Strategic Models Former faculty Columbia Business School. Extensive experience in medical devices and data management World-renowned urologist and researcher. Co-founded numerous technology initiatives, including MediData Solutions (NASDAQ:MDSO) the largest clinical trials data management company.
- Prof. Richard Stone
Director
Serves on the board of directors of multiple technology companies, including Powermat, Espro-Accoustiguide Group, Wellsense Technologies, NanoX Imaging and Check-Cap. Cofounded Lev Pharmaceuticals, Inc. which was sold to ViroPharma in 2008 for nearly $450 million in upfront consideration.
Board of Directors
Dennis McGrath Director
Currently serves as President, CFO and board director
- f PhotoMedex, Inc. (NasdaqGS: PHMD,) joining the
company in 2000
Erez Raphael CEO & President
20 years of experience in building product organizations – from Design to commercialization. Formerly with Amdocs (NYSE: DOX) and Nokia-Siemens.
www.mydario.com
Prof Itamar Raz, MD Head of SAB Gary Scheiner CDE MS Hope Warshaw MMSc RD CDE BC-ADM
Head of Diabetes Unit and Research Center, Hadassah Medical Center; Israel National Council of Diabetes of the Israel Ministry of Health; President, Israel Diabetes Research Group. Dietitian and diabetes educator for nearly thirty-five years. Owner of consulting practice, Hope Warshaw Associates, LLC,. Her work today spans from corporate consulting to consumer and professional writing and individual diabetes and weight management counseling.
- Dr. Paul Rosman
DO FACP FACE FACOI
Scientific Advisory Board
- Dr. William Polonsky
PhD
- Dr. Paolo Pozzilli
MD
Professor of Medicine, Endocrinologist and Angiologist at the Munich Diabetes Research Group in Germany. Prof. Standl has developed his career in both Munich, and at the Joslin Diabetes Center at Boston in
- USA. He is retired Director of the Department of Endocrinology,
Diabetology and Metabolism at the Academic Hospital Munich- Schwabing
www.mydario.com
Has lived with type 1 diabetes since 1985 acknowledged as the 2014 Diabetes Educator of the Year by the American Association of Diabetes Educators. Known for his globally-available coaching services at IntegratedDiabetes.com. An internationally recognized expert in the behavioral aspects of diabetes management. Co-founded the Behavioral Diabetes Institute He is author of numerous books, including the famed Diabetes Burnout: What to Do When You Can’t Take It Anymore. Former Senior Medical Advisor at Eli Lilly & Company, has held teaching positions at Ohio University and Northeastern Ohio Universities College of Medicine, as well as served as President or Chair of American Diabetes Association, American Association of Clinical Endocrinologists, Ohio River Chapter, and the Ohio Diabetes Prevention and Control Program
- Dr. Eberhard Standl
MD
Professor of Endocrinology and Metabolic Diseases, Head of Department at the University Campus Bio-Medico in Rome, Italy in charge of the Post- Graduate School and PhD program in Endocrinology and Diabetes. He is also Professor of Diabetes Research at St.Bartholomew’s and the London School of Medicine.
Prof Itamar Raz, MD Head of SAB
Thank You.
Thriving with Diabetes, Together
Thriving with Diabetes In the Health Era